High levels of kinesiophobia were present in 87.2% of patients with coronary artery disease and were a significant predictor of reduced physical performance, including decreased 6-Minute Walk Test distance.
Cross-Sectional (n=52)
No
Kinesiophobia is highly prevalent in patients with coronary artery disease, particularly those with a history of myocardial infarction, and is a significant predictor of reduced physical performance and health-related quality of life.
Effect estimate: B = -9.93 (95% CI -13.60 to -6.30)
p-value: p=<0.001
Introduction: Kinesiophobia is an important risk factor for physical activity and exercise restrictions. It is important to assess kinesiophobia and identify high-risk patients to help prevent sedentary behaviour and increase exercise participation among cardiac patients. Aim: To evaluate kinesiophobia and its association with physical performance, health-related quality of life (HRQOL), patients' limitations and symptoms, and disease history in patients with coronary artery disease (CAD). Material and methods: Fifty-two patients diagnosed with CAD were enrolled in this study. Kinesiophobia was assessed with the Tampa Scale of Kinesiophobia for Heart. The 5× Sit-to-Stand Test (5-STST), the Timed Up and Go Test (TUGT), and the 6-Minute Walk Test (6-MWT) were used to assess physical performance. Patients' limitations and symptoms and HRQOL were evaluated with the Cardiovascular Limitations and Symptoms Profile. CAD duration and history of myocardial infarction (MI) were also recorded. Results: < 0.05). Conclusions: Levels of kinesiophobia are high in patients with CAD, especially in those with a history of MI. Angina is a predictor of kinesiophobia while kinesiophobia is a predictor of both physical performance and HRQOL in CAD patients.
Çakal et al. (Sat,) conducted a cross-sectional in Coronary artery disease (n=52). Kinesiophobia vs. Low kinesiophobia was evaluated on 6-Minute Walk Test (6-MWT) distance (B = -9.93, 95% CI -13.60 to -6.30, p=<0.001). High levels of kinesiophobia were present in 87.2% of patients with coronary artery disease and were a significant predictor of reduced physical performance, including decreased 6-Minute Walk Test distance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: